ICD-10 Code B59 | Pneumocystosis Symptoms, Diagnosis, Billing

Pneumocystosis is a pulmonary infection caused by the fungus Pneumocystis jirovecii, primarily affecting immunocompromised individuals, such as those with HIV/AIDS. It is clinically significant due to its potential to cause severe respiratory distress and complications. Accurate coding with ICD-10 Code B59 facilitates proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code B59 for Pneumocystosis?

ICD-10 Code B59 represents Pneumocystosis, an opportunistic infection caused by Pneumocystis jirovecii. This code is used when documenting cases of Pneumocystosis, particularly in patients with weakened immune systems. It is essential for accurate clinical documentation and billing, especially in settings such as hospitals and outpatient clinics where patients may present with respiratory symptoms.

ICD-10 Code B59 – Clinical Definition and Explanation of Pneumocystosis

Pneumocystosis is primarily caused by the inhalation of Pneumocystis jirovecii, leading to interstitial pneumonia. The condition progresses rapidly in immunocompromised patients, necessitating prompt medical intervention to prevent severe respiratory failure. Early recognition and treatment are critical for improving patient outcomes.

Key Clinical Features:

• Dry cough and dyspnea on exertion
• Fever and chills
• Hypoxemia and respiratory distress
• Chest X-ray findings of bilateral infiltrates

ICD-10 Code B59 for Pneumocystosis – SOAP Notes & Clinical Use

ICD-10 Code B59 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate billing processes.

What Does ICD-10 Code B59 for Pneumocystosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B59 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Pneumocystosis. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B59 – Pneumocystosis

Pneumocystosis requires urgent medical attention, often necessitating hospitalization for severe cases. Treatment typically involves specific antibiotic therapy and supportive care.

Antibiotic Therapy:

• First-line: Trimethoprim-sulfamethoxazole (TMP-SMX) for 21 days
• Alternative: Pentamidine for patients unable to tolerate TMP-SMX
• Adjunctive corticosteroids for severe cases

Supportive Care:

• Oxygen therapy to manage hypoxemia
• Fluid management to prevent dehydration
• Monitoring for respiratory distress and complications

Infection Control:

• Implement standard precautions to prevent transmission
• Isolation of immunocompromised patients during outbreaks
• Education on hygiene practices for patients and caregivers

How to Document Symptoms of Pneumocystosis (ICD-10 B59) in SOAP Notes

Subjective:

• Patient reports persistent dry cough for two weeks
• Experiencing shortness of breath, especially with exertion
• Fever and chills noted over the past few days
• History of HIV with a CD4 count of 150 cells/mm³

Objective:

• Auscultation reveals bilateral crackles
• Respiratory rate: 24 breaths per minute
• Oxygen saturation: 88% on room air
• Chest X-ray shows bilateral ground-glass opacities

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Pneumocystosis (ICD-10 Code B59)

Assessment:

• Diagnosis: Pneumocystosis (ICD-10 B59), moderate severity
• Consider underlying HIV/AIDS as a contributing factor
• Monitor for potential respiratory failure

Plan:

• Initiate treatment with TMP-SMX for 21 days
• Provide supplemental oxygen as needed
• Educate patient on recognizing worsening symptoms
• Schedule follow-up in one week to reassess respiratory status

Treatment & Plan Section for ICD-10 Code B59 – Pneumocystosis

• Administer first-line antibiotics (TMP-SMX) as per guidelines
• Implement supportive measures, including oxygen therapy
• Educate on symptom management and when to seek care
• Regular monitoring of respiratory function and follow-up appointments

Using ICD-10 Code B59 for Pneumocystosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes
• Use ICD-10 Code B59 for all related billing to support claims
• Align treatment plans with clinical guidelines for justifiable billing
• Include relevant CPT codes that correspond with the services provided

Related ICD-10 Codes Often Used with Pneumocystosis

• B20 – HIV disease resulting in opportunistic infections

ICD-10 Code B59 in Medical Billing and Insurance for Pneumocystosis

ICD-10 Code B59 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate claims processing.

Billing Notes:

• Document all relevant clinical findings and treatments to support the ICD-10 claim.
• Use B59 in conjunction with other codes for comprehensive billing.
• Ensure that the diagnosis is clearly linked to the services provided in the medical record.

Common CPT Pairings: